日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world efficacy and safety of disitamab vedotin (RC48) plus PD-1 inhibitors in advanced urothelial carcinoma: a single-center retrospective study

disitamab vedotin (RC48) 联合 PD-1 抑制剂治疗晚期尿路上皮癌的真实世界疗效和安全性:一项单中心回顾性研究

Lv, Ya-Hui; Cui, Xiao-Ran; Yu, Lu; Li, Tao; Liu, Chang; Liu, Mei-Cen; Ji, Yin-Min; Xiao, Shu-Yan; Hu, Yi; Zhang, Tong; Liu, Zhe-Feng

Neuropeptide-mediated activation of astrocytes improves stress resilience in mice by modulating cortical neural synapses

神经肽介导的星形胶质细胞激活通过调节皮层神经突触来提高小鼠的应激抵抗力。

Cui, Jing; Wang, Xiao-Ran; Yu, Jie; Zhang, Bo-Rui; Shi, Ya-Fei; So, Kwok-Fai; Zhang, Li; Wei, Ji-An

Molecularly imprinted polymer/CdTe quantum dots-decorated polymer optic fiber microprobes for Amoxicillin detection

用于检测阿莫西林的分子印迹聚合物/CdTe量子点修饰的聚合物光纤微探针

Liang, Jianfeng; Wu, Qixuan; Xiao, Ran; Yu, Ruijie; Chen, Hao; Tang, Yangjie; Zhang, Jie; Liu, Chenchen; Yang, Guowei; Lei, Hongxiang

From Ulcer to Amputation: A Systematic Review of Prognostic Models for Diabetic Foot Ulcer Amputation

从溃疡到截肢:糖尿病足溃疡截肢预后模型的系统评价

Xie, Xiao-Ran; Yu, Ming-Feng; Xu, Rong; Liu, Yu; Zhang, Jing

Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer

外周血细胞毒性T淋巴细胞可预测HER2阳性晚期乳腺癌一线治疗的无进展生存期

Liu, Xiao-Ran; Yu, Jian-Jun; Song, Guo-Hong; Di, Li-Jun; Jiang, Han-Fang; Yan, Ying; Liang, Xu; Zhang, Ru-Yan; Ran, Ran; Wang, Jing; Bai, Han; Jia, Shi-Dong; Li, Hui-Ping

[Blocking programmed death-ligand 1 attenuates maturation inhibition of dendritic cells by co-cultured breast cancer cells]

阻断程序性死亡配体1可减弱共培养乳腺癌细胞对树突状细胞的成熟抑制作用

Xiao-Ran Yu, Qiao-Sheng Wen, Yi Xiao, Rui Tang, Fu-Xi Li, Wen-Feng Shao, Yan-Lin Yu, Jing-Bo Xiong